/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./
CALGARY, Oct. 11, 2018 /CNW/ - RMMI Corp. (CSE: RMMI) ("RMMI" or the "Company") today announced that it has voluntarily filed its Annual Information Form ("AIF") for the fiscal year ended December 31, 2017 on SEDAR at www.sedar.com.
The Company is also pleased to provide an update on its hemp cultivation program. In February 2018, RMMI received its license to produce industrial hemp at its cultivation and production facility in the County of Newell, two hours east of Calgary. The Company subsequently purchased its first train of aeroponics cultivation equipment from AEssence Corporation. RMMI's objective is to utilize industrial hemp, which is almost genetically identical to marijuana, to develop a detailed understanding of the use of its aeroponics equipment, to hone its standard operating procedures and fine-tune its quality assurance plan, in advance of receiving a license to produce marijuana under Health Canada's Access to Cannabis for Medical Purposes Regulations (Canada).
Hemp cultivation was initiated by germinating hemp seeds at the Company's facility. The time from germination to harvesting of approximately 80 large and healthy plants in RMMI's aeroponics cultivation system was nine weeks. Actual plant growth to maturity took eight weeks.
RMMI's CEO Earl Connors, commented, "The successfully-completed hemp cultivation cycle enabled the Company to collect valuable information including nutrient and pH requirements at different stages of growth, to work on standardisation of environmental conditions such as temperature, humidity, lighting, electroconductivity of the nutrient-water mix, and other factors. RMMI is applying this information in a new hemp cultivation program now underway, to enhance its use and knowledge of its aeroponics equipment and further refine its procedures and quality program."
About RMMI Corp.
RMMI is an Alberta-based company focused on the production, cultivation and sale of medical marijuana in various forms. RMMI, through its wholly-owned subsidiary, Rocky Mountain is a late stage applicant under the Access to Cannabis for Medical Purposes Regulations (Canada) and is in the process of obtaining the requisite license to commence cannabis production and operations. Rocky Mountain blends science with nature using aeroponic cultivation and CO2 extraction. Rocky Mountain intends to produce high-purity, organic-quality cannabis oils. Its team will employ leading, commercially-available science and technology to maximize production yields and product quality as a low-cost producer, while reducing risk to its crops and its business.
For more information please visit www.rmmi.ca.
Forward Looking Statements
Certain statements contained in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of the applicable securities legislation (collectively, "forward-looking statements"). These statements relate to management's expectations about future events, results of operations and RMMI's future performance (both operational and financial) and business prospects. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Unless otherwise indicated, these statements speak only as of the date of this news release. In particular, this news release contains forward-looking statements pertaining RMMI's future hemp cultivation program and the use of information derived from such program to further refine the Company's procedures and quality programs.
Forward-looking statements are based on certain assumptions and analyses made by RMMI in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate and are subject to risks and uncertainties. In making the forward-looking statements, RMMI has made various material assumptions, including but not limited to, receipt of applicable regulatory licences from Health Canada, material assumptions relating to general business and economic conditions and RMMI's ability to successfully execute its business plans strategy. Although RMMI believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and RMMI cannot assure that actual results will be consistent with the forward-looking statements included in this news release. Given these risks, uncertainties and assumptions, readers should not place undue reliance on the forward-looking statements in this news release and should review the various risk factors set forth in RMMI's AIF dated October 10, 2018.
The forward-looking statements included in this news release are expressly qualified by this cautionary statement and, except as otherwise indicated, are made as of the date of this news release. RMMI does not undertake any obligation to publicly update or revise any forward-looking statements or departures from them except as required by applicable securities laws. All of the forward-looking statements contained in this news release are expressly qualified by the foregoing cautionary statements.
For further information: Earl Connors, President and Chief Executive Officer; Investor Relations Contact: George Jurcic, Director of Corporate Development, email@example.com, 403-984-6446